At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases. We fund early-stage companies who need capital to support IND submission and clinical trials.

Venture Capital

Therapeutics

Life Sciences

Biotechnology

Global BioAccess Fund

Global BioAccess Fund's headquarters in New York, United States

Description

People (6)

Lisa Wisniewski

Sonia Gulati

Sally Adua

Kevin Cyr

Ribhav Gupta

Michael D Krepps

Jobs